Cardiff Oncology, Inc. (NASDAQ: CRDF) stock is rising remarkably on the US stock charts today. As of the latest check, CRDF shares were up 50.31%,
On January 18, Cardiff Oncology Inc. (CRDF) announced new data from its lead clinical program in KRAS-mutated metastatic colorectal cancer. While the company was happy
Shares of Cardiff Oncology, Inc. (NASDAQ: CRDF) were traded up 39.59% after it announced that Onvansertib has shown the clinical benefit in colorectal cancer. The
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.